# FDA Inspection 1208645 - OneBlood - Crestview - May 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/oneblood-crestview/aee477d4-102b-4e40-ac0b-5f3f9fd0061f
Source feed: FDA_Inspections

> FDA Inspection 1208645 for OneBlood - Crestview on May 29, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208645
- Company Name: OneBlood - Crestview
- Inspection Date: 2023-05-29
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1208645 - 2023-05-29](https://www.keypedia.com/records/fda_inspections/oneblood-crestview/2f9c9da9-8a3c-4836-aa2a-d5f97263f224)
- [FDA Inspection 1086056 - 2019-04-09](https://www.keypedia.com/records/fda_inspections/oneblood-crestview/5fca8b1f-7699-4c80-ac68-2563e60192ee)
- [FDA Inspection 1012287 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/oneblood-crestview/9af6dff1-c5a8-4767-987a-fba6661e4c6b)
- [FDA Inspection 941335 - 2015-09-03](https://www.keypedia.com/records/fda_inspections/oneblood-crestview/e3fad9d5-cf05-4264-bb5b-b309e74abe42)
- [FDA Inspection 864463 - 2014-01-31](https://www.keypedia.com/records/fda_inspections/oneblood-crestview/20bd3aed-33ba-4b09-93d4-617a220e2539)

Company: https://www.keypedia.com/companies/oneblood-crestview/04f563d4-1df2-4a6e-a665-deb45e0e3bbe

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d